GEV vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

GEV

56.3
AI Score
VS
GEV Wins

EMR

54.9
AI Score

Investment Advisor Scores

GEV

56score
Recommendation
HOLD

EMR

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GEV EMR Winner
Forward P/E 31.8471 20.3252 EMR
PEG Ratio 1.5296 2.0325 GEV
Revenue Growth 21.9% 2.9% GEV
Earnings Growth 32.8% 27.9% GEV
Tradestie Score 56.3/100 54.9/100 GEV
Profit Margin 23.0% 13.4% GEV
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GEV 1M: -9.4% · 3M: -5.1% EMR 1M: +10.9% · 3M: +12.2%

Current Technical Phase

GEV

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.7%) with fading momentum, RSI 48

RSI (14): 48.3 · Price: $1008.62

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 65

RSI (14): 65.3 · Price: $154.20

Fundamentals Snapshot

Metric GEV EMR
Market Cap
Forward P/E 39.8 20.9
Trailing P/E 25.8 33.8
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.2% 0.5%
Operating Margin 0.1% 0.2%
EPS 38.00 4.40
Dividend Yield 0.00% 0.01%

Frequently Asked Questions

Based on our detailed analysis, GEV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.